The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.
<h4>Background</h4>Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-10-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1004110 |
| _version_ | 1811232048567812096 |
|---|---|
| author | Dafina Petrova Zuzana Špacírová Nicolás Francisco Fernández-Martínez Ana Ching-López Dunia Garrido Miguel Rodríguez-Barranco Marina Pollán Daniel Redondo-Sánchez Carolina Espina Camila Higueras-Callejón Maria José Sánchez |
| author_facet | Dafina Petrova Zuzana Špacírová Nicolás Francisco Fernández-Martínez Ana Ching-López Dunia Garrido Miguel Rodríguez-Barranco Marina Pollán Daniel Redondo-Sánchez Carolina Espina Camila Higueras-Callejón Maria José Sánchez |
| author_sort | Dafina Petrova |
| collection | DOAJ |
| description | <h4>Background</h4>Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration of these intervals for various types of cancer and compared it across high- and lower-income countries.<h4>Methods and findings</h4>We conducted a systematic review with meta-analysis (prospectively registered protocol CRD42020200752). Three databases (MEDLINE, Embase, and Web of Science) and information sources including grey literature (Google Scholar, OpenGrey, EThOS, ProQuest Dissertations & Theses) were searched. Eligible articles were published during 2009 to 2022 and reported the duration of the following intervals in adult patients diagnosed with primary symptomatic cancer: patient interval (from the onset of symptoms to first presentation to a healthcare professional), diagnostic interval (from first presentation to diagnosis), and treatment interval (from diagnosis to treatment start). Interval duration was recorded in days and study medians were combined in a pooled estimate with 95% confidence intervals (CIs). The methodological quality of studies was assessed using the Aarhus checklist. A total of 410 articles representing 68 countries and reporting on 5,537,594 patients were included. The majority of articles reported data from high-income countries (n = 294, 72%), with 116 (28%) reporting data from lower-income countries. Pooled meta-analytic estimates were possible for 38 types of cancer. The majority of studies were conducted on patients with breast, lung, colorectal, and head and neck cancer. In studies from high-income countries, pooled median patient intervals generally did not exceed a month for most cancers. However, in studies from lower-income countries, patient intervals were consistently 1.5 to 4 times longer for almost all cancer sites. The majority of data on the diagnostic and treatment intervals came from high-income countries. Across both high- and lower-income countries, the longest diagnostic intervals were observed for hematological (71 days [95% CI 52 to 85], e.g., myelomas (83 days [47 to 145])), genitourinary (58 days [50 to 77], e.g., prostate (85 days [57 to 112])), and digestive/gastrointestinal (57 days [45 to 67], e.g., colorectal (63 days [48 to 78])) cancers. Similarly, the longest treatment intervals were observed for genitourinary (57 days [45 to 66], e.g., prostate (75 days [61 to 87])) and gynecological (46 days [38 to 54], e.g., cervical (69 days [45 to 108]) cancers. In studies from high-income countries, the implementation of cancer-directed policies was associated with shorter patient and diagnostic intervals for several cancers. This review included a large number of studies conducted worldwide but is limited by survivor bias and the inherent complexity and many possible biases in the measurement of time points and intervals in the cancer treatment pathway. In addition, the subintervals that compose the diagnostic interval (e.g., primary care interval, referral to diagnosis interval) were not considered.<h4>Conclusions</h4>These results identify the cancers where diagnosis and treatment initiation may take the longest and reveal the extent of global disparities in early diagnosis and treatment. Efforts should be made to reduce help-seeking times for cancer symptoms in lower-income countries. Estimates for the diagnostic and treatment intervals came mostly from high-income countries that have powerful health information systems in place to record such information. |
| first_indexed | 2024-04-12T10:56:42Z |
| format | Article |
| id | doaj.art-547eb9e3031d4baf9d1ea797b335878c |
| institution | Directory Open Access Journal |
| issn | 1549-1277 1549-1676 |
| language | English |
| last_indexed | 2024-04-12T10:56:42Z |
| publishDate | 2022-10-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj.art-547eb9e3031d4baf9d1ea797b335878c2022-12-22T03:36:05ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762022-10-011910e100411010.1371/journal.pmed.1004110The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.Dafina PetrovaZuzana ŠpacírováNicolás Francisco Fernández-MartínezAna Ching-LópezDunia GarridoMiguel Rodríguez-BarrancoMarina PollánDaniel Redondo-SánchezCarolina EspinaCamila Higueras-CallejónMaria José Sánchez<h4>Background</h4>Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration of these intervals for various types of cancer and compared it across high- and lower-income countries.<h4>Methods and findings</h4>We conducted a systematic review with meta-analysis (prospectively registered protocol CRD42020200752). Three databases (MEDLINE, Embase, and Web of Science) and information sources including grey literature (Google Scholar, OpenGrey, EThOS, ProQuest Dissertations & Theses) were searched. Eligible articles were published during 2009 to 2022 and reported the duration of the following intervals in adult patients diagnosed with primary symptomatic cancer: patient interval (from the onset of symptoms to first presentation to a healthcare professional), diagnostic interval (from first presentation to diagnosis), and treatment interval (from diagnosis to treatment start). Interval duration was recorded in days and study medians were combined in a pooled estimate with 95% confidence intervals (CIs). The methodological quality of studies was assessed using the Aarhus checklist. A total of 410 articles representing 68 countries and reporting on 5,537,594 patients were included. The majority of articles reported data from high-income countries (n = 294, 72%), with 116 (28%) reporting data from lower-income countries. Pooled meta-analytic estimates were possible for 38 types of cancer. The majority of studies were conducted on patients with breast, lung, colorectal, and head and neck cancer. In studies from high-income countries, pooled median patient intervals generally did not exceed a month for most cancers. However, in studies from lower-income countries, patient intervals were consistently 1.5 to 4 times longer for almost all cancer sites. The majority of data on the diagnostic and treatment intervals came from high-income countries. Across both high- and lower-income countries, the longest diagnostic intervals were observed for hematological (71 days [95% CI 52 to 85], e.g., myelomas (83 days [47 to 145])), genitourinary (58 days [50 to 77], e.g., prostate (85 days [57 to 112])), and digestive/gastrointestinal (57 days [45 to 67], e.g., colorectal (63 days [48 to 78])) cancers. Similarly, the longest treatment intervals were observed for genitourinary (57 days [45 to 66], e.g., prostate (75 days [61 to 87])) and gynecological (46 days [38 to 54], e.g., cervical (69 days [45 to 108]) cancers. In studies from high-income countries, the implementation of cancer-directed policies was associated with shorter patient and diagnostic intervals for several cancers. This review included a large number of studies conducted worldwide but is limited by survivor bias and the inherent complexity and many possible biases in the measurement of time points and intervals in the cancer treatment pathway. In addition, the subintervals that compose the diagnostic interval (e.g., primary care interval, referral to diagnosis interval) were not considered.<h4>Conclusions</h4>These results identify the cancers where diagnosis and treatment initiation may take the longest and reveal the extent of global disparities in early diagnosis and treatment. Efforts should be made to reduce help-seeking times for cancer symptoms in lower-income countries. Estimates for the diagnostic and treatment intervals came mostly from high-income countries that have powerful health information systems in place to record such information.https://doi.org/10.1371/journal.pmed.1004110 |
| spellingShingle | Dafina Petrova Zuzana Špacírová Nicolás Francisco Fernández-Martínez Ana Ching-López Dunia Garrido Miguel Rodríguez-Barranco Marina Pollán Daniel Redondo-Sánchez Carolina Espina Camila Higueras-Callejón Maria José Sánchez The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. PLoS Medicine |
| title | The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. |
| title_full | The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. |
| title_fullStr | The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. |
| title_full_unstemmed | The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. |
| title_short | The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. |
| title_sort | patient diagnostic and treatment intervals in adult patients with cancer from high and lower income countries a systematic review and meta analysis |
| url | https://doi.org/10.1371/journal.pmed.1004110 |
| work_keys_str_mv | AT dafinapetrova thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT zuzanaspacirova thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT nicolasfranciscofernandezmartinez thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT anachinglopez thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT duniagarrido thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT miguelrodriguezbarranco thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT marinapollan thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT danielredondosanchez thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT carolinaespina thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT camilahiguerascallejon thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT mariajosesanchez thepatientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT dafinapetrova patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT zuzanaspacirova patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT nicolasfranciscofernandezmartinez patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT anachinglopez patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT duniagarrido patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT miguelrodriguezbarranco patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT marinapollan patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT danielredondosanchez patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT carolinaespina patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT camilahiguerascallejon patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis AT mariajosesanchez patientdiagnosticandtreatmentintervalsinadultpatientswithcancerfromhighandlowerincomecountriesasystematicreviewandmetaanalysis |